Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

1. Gestational Diabetes

Gestational Diabetes © 2002 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Gestational Diabetes Screening and Treatment Guideline Major Changes as of April 2018 2 Screening Recommendations and Tests 2 Diagnosis 3 Treatment Goals 3 Lifestyle modifications/non-pharmacologic options 3 Pharmacologic options 4 Additional Testing/Monitoring Antenatal monitoring 7 Follow-up after delivery 7 Referral 7 Evidence Summary 8 References 11 Guideline Development Process and Team 12 Last (...) in the guidelines may not be appropriate for use in all circumstances. The inclusion of a recommendation in a guideline does not imply coverage. A decision to adopt any particular recommendation must be made by the provider in light of the circumstances presented by the individual patient. 2 Major Changes as of April 2018 New Previous 2-step gestational diabetes (GDM) screening test 1-step GDM screening test Follow Canadian Diabetes Association blood glucose cutoffs for diagnosis: • Fasting = 95 mg/dL or • 1

2018 Kaiser Permanente Clinical Guidelines

2. Gestational diabetes mellitus

BMI: Body Mass Index DM: Diabetes Mellitus GDM: Gestational Diabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin OGTT: Oral glucose tolerance test =: greater than or equal to : greater than Queensland Clinical Guideline: Gestational diabetes mellitus. Guideline No: MN15.33-V1-R20 Assess all women for risk factors GDM care GDM diagnosis OGTT (preferred test for diagnosis) One or more of: • Fasting = 5.1 mmol/L • 1 hour = 10 mmol/L • 2 hour = 8.5 mmol/L HbA1c (if OGTT not suitable (...) • Maternal age = 40 years • Family history DM (1 st degree relative or sister with GDM) • Previous macrosomia (birth weight > 4500 g or > 90 th percentile • Previous perinatal loss • Polycystic Ovarian Syndrome • Medications (corticosteroids, antipsychotics) • Multiple pregnancy Queensland Clinical Guideline: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 4 of 38 Flowchart: Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease

2015 Queensland Health

3. Clinical Guideline: Gestational diabetes mellitus

75 10.0 86 11.0 97 12.0 108 Postnatal follow-up • Delay OGTT for 12 months or • If concerned about type 2 diabetes: o Continue self-monitoring o HbA1c at 4–6 months • Notify GP BGL: blood glucose level, BMI: body mass index, DM: diabetes mellitus, FBG: fasting blood glucose GDM: gestational diabetes mellitus, GP: general practitioner, HbA1c: glycated haemoglobin, OGTT: oral glucose tolerance test, =: greater than or equal to >: greater than Maternity and Neonatal C linical G uideline Department (...) : Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 3 of 38 24-28 weeks gest 2 hour 75 g OGTT Routine antenatal care Risk factors? OGTT normal? BGL: Blood glucose level BMI: Body Mass Index DM: Diabetes Mellitus GDM: Gestational Diabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin

2020 Queensland Health

4. Gestational diabetes

Gestational diabetes Top results for gestational diabetes - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look (...) like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for gestational diabetes The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials

2018 Trip Latest and Greatest

5. Gestational diabetes mellitus

Gestational diabetes mellitus Gestational diabetes mellitus - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Gestational diabetes mellitus Last reviewed: February 2019 Last updated: April 2018 Summary Develops during pregnancy and is usually diagnosed at 24 to 28 weeks of gestation on the basis of elevated plasma glucose levels on glucose tolerance testing. Goal of therapy is to achieve maternal glucose levels (...) that are as close to normal as possible in order to avoid fetal macrosomia and complications. Initial therapy for gestational diabetes is usually dietary modification. Insulin is started when acceptable glucose levels cannot be maintained with diet alone. Maternal postnatal testing for diabetes or impaired glucose tolerance is performed at least 6 weeks following delivery. The risk for recurrence of GDM in subsequent pregnancies or progression to type 2 diabetes is high. Definition Gestational diabetes mellitus

2018 BMJ Best Practice

6. Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. Full Text available with Trip Pro

Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. Gestational diabetes mellitus (GDM) is a common medical condition that complicates pregnancy and causes adverse maternal and fetal outcomes. At present, most treatment strategies focus on normalisation of maternal blood glucose values with use of diet, lifestyle modification, exercise, oral anti-hyperglycaemics and insulin. This has been shown to reduce (...) the incidence of adverse outcomes, such as birth trauma and macrosomia. However, this involves intensive monitoring and treatment of all women with GDM. We propose that using medical imaging to identify pregnancies displaying signs of being affected by GDM could help to target management, allowing low-risk women to be spared excessive intervention, and facilitating better resource allocation.We wanted to address the following question: in women with gestational diabetes, does the use of fetal imaging plus

2019 Cochrane

7. Gestational Diabetes

Gestational Diabetes Gestational Diabetes Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Gestational Diabetes Gestational Diabetes (...) Aka: Gestational Diabetes II. Epidemiology: Prevalence Overall: 6% of pregnant women in U.S. High risk groups (see below): 14% III. Pathophysiology Pancreatic Beta cell hyperplasia is normal in pregnancy Higher g and postprandial levels Placental hormones increase (esp. third trimester) Gestational Diabetes results when increased beta cell function does not overcome IV. Risk Factors Maternal Age > 35 years old (OR 1.6) of in first degree relative (RR 1.7) >25 kg/m2 (OR 3.2) Weight gain >11 lb (5

2018 FP Notebook

8. Pregnancy Health: Lifestyle Interventions to Reduce the Risk of Gestational Diabetes

Pregnancy Health: Lifestyle Interventions to Reduce the Risk of Gestational Diabetes Pregnancy Health: Gestational Diabetes | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) December 2017 Audience Adults Parents/Caregivers Setting Clinical/Health Systems Community Strategy Counseling Health (...) Education Pregnancy Health: Lifestyle Interventions to Reduce the Risk of Gestational Diabetes Tabs Snapshot Summary of CPSTF Finding The lifestyle interventions delivered during the first two trimesters of pregnancy to reduce the risk of gestational diabetes. The CPSTF finds Strong evidence of effectiveness for lifestyle interventions that provide supervised exercise classes, either alone or in combination with other components Sufficient evidence of effectiveness for lifestyle interventions

2017 Community Preventive Services Task Force

9. Gestational Diabetes Mellitus

Gestational Diabetes Mellitus Sign In (ACOG) Sign in to your ACOG account Email is required. Please enter valid Email. was not found in our system. Would you like to associated with your account? Forgot your email address? JSOG Member? © 2019 - American College of Obstetricians and Gynecologists

2018 American College of Obstetricians and Gynecologists

10. Gestational diabetes

Gestational diabetes Evidence Maps - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4

2018 Trip Evidence Maps

11. Periodontal Disease is a Risk Factor for the Development of Gestational Diabetes Mellitus

Periodontal Disease is a Risk Factor for the Development of Gestational Diabetes Mellitus UTCAT3223, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Periodontal Disease is a Risk Factor for the Development of Gestational Diabetes Mellitus Clinical Question In pregnant women, does having periodontal disease increase the risk of gestational diabetes mellitus (GDM)? Clinical Bottom Line Studies have shown that periodontal (...) disease and its inflammatory mediators are associated with an increased risk for the development of gestational diabetes. This is based on a meta-analysis of 5,724 pregnant patients including 624 cases of GDM. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Abariga/2016 Females with periodontal disease Meta-Analysis Key results Forty-four articles were reviewed, and 10 studies met the eligibility criteria

2017 UTHSCSA Dental School CAT Library

12. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. Full Text available with Trip Pro

Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. Gestational diabetes is a type of diabetes that occurs during pregnancy. Women with gestational diabetes are more likely to experience adverse health outcomes such as pre-eclampsia or polyhydramnios (excess amniotic fluid). Their babies are also more likely to have health complications such as macrosomia (birthweight > 4000 g) and being large-for-gestational age (...) (birthweight above the 90th percentile for gestational age). Current clinical guidelines support elective birth, at or near term in women with gestational diabetes to minimise perinatal complications, especially those related to macrosomia.This review replaces a review previously published in 2001 that included "diabetic pregnant women", which has now been split into two reviews. This current review focuses on pregnant women with gestational diabetes and a sister review focuses on women with pre-existing

2018 Cochrane

13. SMFM Statement Pharmacological treatment of gestational diabetes Full Text available with Trip Pro

SMFM Statement Pharmacological treatment of gestational diabetes SMFM Statement: Pharmacological treatment of gestational diabetes - American Journal of Obstetrics & Gynecology Email/Username: Password: Remember me Search Terms Search within Search Share this page: Access provided by Volume 218, Issue 5, Pages B2–B4 SMFM Statement: Pharmacological treatment of gestational diabetes Society of Maternal-Fetal Medicine (SMFM) Publications Committee ∗ Society for Maternal-Fetal Medicine, Washington (...) , DC DOI: | Publication History Published online: February 03, 2018 Expand all Collapse all Treatment for gestational diabetes mellitus (GDM) is associated with improved perinatal outcomes that include reduced frequency of hypertensive disorders of pregnancy, delivery of a large-for-gestational-age (LGA) infant, shoulder dystocia, and cesarean delivery. x 1 Landon, M.B., Spong, C.Y., Thom, E. et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med . 2009

2018 Society for Maternal-Fetal Medicine

14. Systematic review with meta analysis: In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin

Systematic review with meta analysis: In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our (...) or password? You are here In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin Article Text Therapeutics/Prevention Systematic review with meta analysis In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin Dana Carroll , Kristi W Kelley

2015 Evidence-Based Medicine

15. A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS

A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS (GRACES) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02080377 Recruitment Status : Completed First Posted

2014 Clinical Trials

16. Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes Full Text available with Trip Pro

Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes Metformin is an emerging option for treating gestational diabetes (GDM). However, because metformin crosses the placenta, patients and clinicians are concerned with its long-term effect on child health.To estimate the association of treating GDM with metformin vs insulin with child growth and development.Population-based cohort study of New Zealand women treated (...) with metformin or insulin for GDM from 2005 to 2012 and their children. This study linked national health care data to create a cohort of mothers and their children, including data from maternity care, pharmaceutical dispensing, hospitalizations, demographic records, and the B4 School Check (B4SC) preschool health assessment. Women treated pharmacologically with metformin or insulin during pregnancy were included. We excluded pregnancies with evidence of diabetes and deliveries prior to 2013. Liveborn

2019 EvidenceUpdates

17. Health app: GDm-Health for people with gestational diabetes

Health app: GDm-Health for people with gestational diabetes Health app: GDm-Health for people with Health app: GDm-Health for people with gestational diabetes gestational diabetes Medtech innovation briefing Published: 13 November 2017 nice.org.uk/guidance/mib131 pathways Summary Summary About this app GDm-Health is a health application designed for people with gestational diabetes to allow for remote monitoring of blood glucose levels and communication with healthcare professionals. The mobile (...) a positive impact for people with gestational diabetes. There is some evidence that the app is a reliable method to communicate blood glucose levels and improves patient satisfaction with their care. However, there is currently no evidence comparing GDm-Health with standard care and so the impact on clinical outcomes is uncertain. Cost and resource impact Cost and resource impact: Cost savings may arise from reducing the need for face-to-face appointments but the overall resource impact has not been

2017 National Institute for Health and Clinical Excellence - Advice

18. Use of a web-based educational intervention to improve knowledge of healthy diet and lifestyle in women with Gestational Diabetes Mellitus compared to standard clinic-based education. Full Text available with Trip Pro

Use of a web-based educational intervention to improve knowledge of healthy diet and lifestyle in women with Gestational Diabetes Mellitus compared to standard clinic-based education. This study introduced a web-based educational intervention for Australian women with gestational diabetes mellitus (GDM). The aim was to improve knowledge on healthy diet and lifestyle in GDM. Evaluation of the intervention explored women's knowledge and understanding of GDM, healthy diet, healthy food

2017 BMC pregnancy and childbirth Controlled trial quality: uncertain

19. A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes

A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes (DESI-GDM) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov

2018 Clinical Trials

20. Gestational Diabetes

Gestational Diabetes Gestational Diabetes Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Gestational Diabetes Gestational Diabetes (...) Aka: Gestational Diabetes II. Epidemiology: Prevalence Overall: 6% of pregnant women in U.S. High risk groups (see below): 14% III. Pathophysiology Pancreatic Beta cell hyperplasia is normal in pregnancy Higher g and postprandial levels Placental hormones increase (esp. third trimester) Gestational Diabetes results when increased beta cell function does not overcome IV. Risk Factors Maternal Age > 35 years old (OR 1.6) of in first degree relative (RR 1.7) >25 kg/m2 (OR 3.2) Weight gain >11 lb (5

2015 FP Notebook